Differential expression of the estrogen receptor beta (ERbeta) in human prostate tissue, premalignant changes, and in primary, metastatic, and recurrent prostatic adenocarcinoma
- PMID: 12497580
- DOI: 10.1002/pros.10171
Differential expression of the estrogen receptor beta (ERbeta) in human prostate tissue, premalignant changes, and in primary, metastatic, and recurrent prostatic adenocarcinoma
Abstract
Background: Estrogen signaling mediated by the estrogen receptor beta (ERbeta) has potential implications in normal and abnormal prostate growth. Few studies have addressed this issue in human prostate tissue leaving conflicting results on the immunolocalization of the ERbeta in benign and neoplastic lesions.
Methods: Using a new monoclonal antibody, the current study reports on the differential expression of the ERbeta in tissue sections from 132 patients with prostate cancer.
Results: The prostatic epithelium expressed the ERbeta extensively in secretory luminal cell types and at lower levels in basal cells. Atrophic changes of the peripheral zone (PZ) were more immunoreactive than hyperplastic lesions of the transition zone (TZ). When compared with glandular tissue of the PZ, high-grade prostatic intraepithelial neoplasia (HGPIN) revealed decreased levels of the ERbeta in 30 of 47 cases and was unreactive in six lesions. In informative cases with suitable internal controls, all primary tumors (n = 60), lymph node (n = 7), and bone metastases (n = 5) expressed the ERbeta at variable degree. No correlation was found between the ERbeta status, the primary Gleason grade (P = 0.254), and the pathological stage (P = 0.157). Recurrent adenocarcinoma revealed markedly decreased levels in 15 of 40 cases and was ERbeta negative in five recurrent lesions.
Conclusions: The secretory epithelium is a major target of ERbeta-mediated estrogen signaling in the human prostate. Its downregulation in HGPIN is consistent with chemopreventive effects that the ERbeta may exert on the prostatic epithelium. The continuous expression of the receptor protein at significant levels in untreated primary and metastatic adenocarcinoma indicates that these tumors can use estrogens through an ERbeta-mediated pathway. The partial loss of the ERbeta in recurrent tumors after androgen-deprivation may reflect the androgen-dependence of ERbeta gene expression in human prostate cancer.
Copyright 2002 Wiley-Liss, Inc.
Similar articles
-
Quantitative RT-PCR analysis of estrogen receptor gene expression in laser microdissected prostate cancer tissue.Prostate. 2009 Jun 1;69(8):810-9. doi: 10.1002/pros.20929. Prostate. 2009. PMID: 19189301
-
Estrogen and prostate cancer: an eclipsed truth in an androgen-dominated scenario.J Cell Biochem. 2007 Nov 1;102(4):899-911. doi: 10.1002/jcb.21529. J Cell Biochem. 2007. PMID: 17786930 Review.
-
Metastases of prostate cancer express estrogen receptor-beta.Urology. 2004 Oct;64(4):814-20. doi: 10.1016/j.urology.2004.05.036. Urology. 2004. PMID: 15491740
-
Apoptotic regulators in prostatic intraepithelial neoplasia (PIN): value in prostate cancer detection and prevention.Prostate Cancer Prostatic Dis. 2005;8(1):7-13. doi: 10.1038/sj.pcan.4500757. Prostate Cancer Prostatic Dis. 2005. PMID: 15477876 Review.
-
Androgen receptor expression in prostatic intraepithelial neoplasia and cancer.J Urol. 1999 Apr;161(4):1229-32. J Urol. 1999. PMID: 10081875
Cited by
-
Nuclear Estrogen Receptors in Prostate Cancer: From Genes to Function.Cancers (Basel). 2023 Sep 20;15(18):4653. doi: 10.3390/cancers15184653. Cancers (Basel). 2023. PMID: 37760622 Free PMC article. Review.
-
Role of Estrogen Receptor β, G-Protein Coupled Estrogen Receptor and Estrogen-Related Receptors in Endometrial and Ovarian Cancer.Cancers (Basel). 2023 May 20;15(10):2845. doi: 10.3390/cancers15102845. Cancers (Basel). 2023. PMID: 37345182 Free PMC article. Review.
-
Molecular Similarities and Differences between Canine Prostate Cancer and Human Prostate Cancer Variants.Biomedicines. 2023 Apr 5;11(4):1100. doi: 10.3390/biomedicines11041100. Biomedicines. 2023. PMID: 37189720 Free PMC article. Review.
-
The ERα-NRF2 signalling axis promotes bicalutamide resistance in prostate cancer.Cell Commun Signal. 2022 Nov 14;20(1):178. doi: 10.1186/s12964-022-00979-0. Cell Commun Signal. 2022. PMID: 36376959 Free PMC article.
-
Role of estrogen receptors in health and disease.Front Endocrinol (Lausanne). 2022 Aug 18;13:839005. doi: 10.3389/fendo.2022.839005. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36060947 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases